Nulibry
Total Payments
$578,412
Transactions
46
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $234,759 | 21 | 4 |
| 2023 | $237,678 | 17 | 0 |
| 2022 | $105,975 | 8 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $566,275 | 32 | 97.9% |
| Travel and Lodging | $12,058 | 10 | 2.1% |
| Food and Beverage | $78.85 | 4 | 0.0% |
Top Doctors Receiving Payments for Nulibry
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Liza Squires | — | Chester Springs, PA | $578,333 | 42 |
| , MD | Clinical Genetics (M.D.) | West Palm Beach, FL | $44.95 | 1 |
| Kuntal Sen | Student in an Organized Health Care Education/Training Program | Atlanta, GA | $22.22 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | Rockland, DE | $6.01 | 1 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Washington, DC | $5.67 | 1 |
Ad
Manufacturing Companies
- Sentynl Therapeutics, Inc. $578,412
Product Information
- Type Drug
- Total Payments $578,412
- Total Doctors 4
- Transactions 46
About Nulibry
Nulibry is a drug associated with $578,412 in payments to 4 healthcare providers, recorded across 46 transactions in the CMS Open Payments database. The primary manufacturer is Sentynl Therapeutics, Inc..
Payment data is available from 2022 to 2024. In 2024, $234,759 was paid across 21 transactions to 4 doctors.
The most common payment nature for Nulibry is "Consulting Fee" ($566,275, 97.9% of total).